Ascendis Pharma Management
Management criteria checks 2/4
Ascendis Pharma's CEO is Jan Mikkelsen, appointed in Dec 2007, has a tenure of 16.42 years. directly owns 0.74% of the company’s shares, worth $58.60M. The average tenure of the management team and the board of directors is 7.8 years and 6.3 years respectively.
Key information
Jan Mikkelsen
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 16.4yrs |
CEO ownership | 0.7% |
Management average tenure | 7.8yrs |
Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Some Confidence Is Lacking In Ascendis Pharma A/S' (NASDAQ:ASND) P/S
Apr 05Ascendis Pharma's Ambitious Vision 2030
Jan 11What Ascendis Pharma A/S' (NASDAQ:ASND) 29% Share Price Gain Is Not Telling You
Dec 21Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?
Nov 10Ascendis Pharma A/S' (NASDAQ:ASND) Popularity With Investors Is Under Threat From Overpricing
Oct 05Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?
Jun 27Analysts Are Betting On Ascendis Pharma A/S (NASDAQ:ASND) With A Big Upgrade This Week
May 05Is Ascendis Pharma (NASDAQ:ASND) Using Debt In A Risky Way?
Feb 18Is Ascendis Pharma (NASDAQ:ASND) A Risky Investment?
Sep 24Ascendis Pharma: TransCon CNP Data Coming Q4
Sep 15Ascendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTH
Aug 31Ascendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug Skytrofa
Aug 11Ascendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain Prospect
Aug 03Here's Why Ascendis Pharma (NASDAQ:ASND) Can Manage Its Debt Despite Losing Money
Jun 10Ascendis Pharma: Biotech Bear Provides Attractive Entry Point
May 09Ascendis: Institutional Buying Activity Now Seen As Good Value By Market-Makers
Apr 29Ascendis Pharma A/S' (NASDAQ:ASND) Intrinsic Value Is Potentially 51% Above Its Share Price
Feb 24Is Ascendis Pharma (NASDAQ:ASND) In A Good Position To Invest In Growth?
Jan 07Ascendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-Makers
Dec 30Ascendis Pharma A/S' (NASDAQ:ASND) Intrinsic Value Is Potentially 97% Above Its Share Price
Sep 24Ascendis Pharma: A Promising Platform And A Rich Valuation
Sep 10We're Hopeful That Ascendis Pharma (NASDAQ:ASND) Will Use Its Cash Wisely
Aug 12Best Biotech Stock (Now): Ascendis Pharma, Where Best = Capital Gain ODDS Next 3 Months
Jun 30CEO
Jan Mikkelsen (63 yo)
16.4yrs
Tenure
Mr. Jan Moller Mikkelsen serves as the Chief Executive Officer, President, Executive Director and Member of Executive Board of Ascendis Pharma A/S since December 2007. He is Director at Eyconis, Inc. He se...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 16.4yrs | no data | 0.74% € 58.6m | |
CFO, Executive VP & Member of Executive Board | 7.8yrs | no data | 0.0070% € 556.0k | |
Executive VP | 16.4yrs | no data | 0.0032% € 257.1k | |
Executive VP | 10.9yrs | no data | 0.0034% € 267.3k | |
Senior VP of Finance & Principal Accounting Officer | less than a year | no data | no data | |
Senior Director of Investor Relations | no data | no data | no data | |
Executive Vice President of Product Supply & Quality | 8.8yrs | no data | 0.0032% € 257.1k | |
Executive VP and Head of Research & Product Development | 8.3yrs | no data | 0.0051% € 400.2k | |
Executive VP & Head of Clinical Development for Oncology | 2.3yrs | no data | no data | |
Head of U.S. Commercial of Endocrinology | 2yrs | no data | no data | |
Head of Global Commercial Strategy of Endocrinology | 2yrs | no data | no data | |
Executive VP & Global Chief Commercial Officer | less than a year | no data | no data |
7.8yrs
Average Tenure
53yo
Average Age
Experienced Management: ASND's management team is seasoned and experienced (7.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 16.4yrs | no data | 0.74% € 58.6m | |
Independent Chairman | 9.5yrs | €123.07k | 0.00068% € 53.8k | |
Independent Director | 1.7yrs | €15.89k | 0% € 0 | |
Independent Director | 7.1yrs | €92.64k | 0.00068% € 53.8k | |
Independent Director | 5.5yrs | €96.17k | 0.0016% € 123.4k | |
Independent Director | 1.7yrs | €17.68k | 0% € 0 |
6.3yrs
Average Tenure
56.5yo
Average Age
Experienced Board: ASND's board of directors are considered experienced (6.3 years average tenure).